The Union Health Ministry has sought strict compliance from all drug manufacturers, in line with the revised Schedule M norms for pharmaceutical products in India. Licences of non-compliant units would be cancelled, the Ministry has warned.
The direction comes after an emergency meeting with all States and Union Territories on Sunday (October 5, 2025) evening, following a report by the Tamil Nadu Drugs Control Department, which found above permissible levels of diethylene glycol (DEG) in samples of Coldri
Continue Reading on The Hindu
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.